Abbott's life support system receives new fda clearances to help doctors treat more critically ill patients

Abbott's centrimag™ blood pump, previously cleared for use up to six hours, now can be used to provide longer-term life support to critically ill patients, providing doctors more time to make critical care decisions abbott's centrimag™ pre-connected pack, which combines a blood pump and oxygenator to form a life support circuit, also received fda clearance for life support lasting less than six hours, helping physicians provide urgent critical care more efficiently and in fewer steps abbott park, ill., april 25, 2023 /prnewswire/ -- abbott (nyse: abt) today announced two new clearances from the u.s. food and drug administration (fda) for the company's industry-leading life support system.
ABT Ratings Summary
ABT Quant Ranking